Compared with traditional tumor markers such as CEA and CA125, LUCAT1 can make up for its deficiency in specificity, help clinical diagnosis of CC as early as possible and timely treatment and improve the prognosis of patients. The gene discussed is LUCAT1; the disease is neoplasm.